| 1 |
Nogueira C, Lemos-senna E, da Silva Vieira E, Sampaio TB, Mallmann MP, Oliveira MS, Bernardi LS, Oliveira PR. β-caryophyllene cationic nanoemulsion for intranasal delivery and treatment of epilepsy: development and in vivo evaluation of anticonvulsant activity. J Nanopart Res 2023;25:19. [DOI: 10.1007/s11051-023-05668-8] [Reference Citation Analysis]
|
| 2 |
Dalvi A, Ravi PR, Uppuluri CT. Design and evaluation of rufinamide nanocrystals loaded thermoresponsive nasal in situ gelling system for improved drug distribution to brain. Front Pharmacol 2022;13:943772. [DOI: 10.3389/fphar.2022.943772] [Reference Citation Analysis]
|
| 3 |
Montegiove N, Calzoni E, Emiliani C, Cesaretti A. Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases. JFB 2022;13:125. [DOI: 10.3390/jfb13030125] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Khan R, Jain P, Zakir F, Aqil M, Alshehri S, Mirza MA, Iqbal Z. Quality and In Vivo Assessment of a Fulvic Acid Complex: A Validation Study. Sci Pharm 2022;90:33. [DOI: 10.3390/scipharm90020033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro MJ, Burgaletto C, Puglisi G, Bernardini R, Cantarella G. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease. Biomedicines 2022;10:985. [DOI: 10.3390/biomedicines10050985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Kumar G, Virmani T, Pathak K, Alhalmi A, Panakanti R. A Revolutionary Blueprint for Mitigation of Hypertension via Nanoemulsion. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/4109874] [Reference Citation Analysis]
|
| 7 |
Qizilbash FF, Ashhar MU, Zafar A, Qamar Z, Annu, Ali J, Baboota S, Ghoneim MM, Alshehri S, Ali A. Thymoquinone-Enriched Naringenin-Loaded Nanostructured Lipid Carrier for Brain Delivery via Nasal Route: In Vitro Prospect and In Vivo Therapeutic Efficacy for the Treatment of Depression. Pharmaceutics 2022;14:656. [DOI: 10.3390/pharmaceutics14030656] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
